400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR-ONC-17013202
结束
/
/
/
2017-10-31
/
/
冠狀動脉疾病
以光學相干斷層掃描評估 Magmaris 鎂合金全吸收式生物血管支植入術
以光學相干斷層掃描評估 Magmaris 鎂合金全吸收式生物血管支植入術
以光學相干斷層掃描評估 Magmaris 鎂合金全吸收式生物血管支植入術
单臂
治疗新技术
N/A
N/A
No
/
30
/
1990-01-01
1990-01-01
/
1. Subject is ≥18 years of age; 2. Subject received Magmaris implantation in Prince of Wale Hospital within 12 months before enrollment; 3. Subject has provided written informed consent.;
请登录查看Subject's physical condition which is contraindicated for coronary angiography;
请登录查看香港中文大學醫學與治療系
/
标新生物GLUETACS2025-12-12
兽药资讯2025-12-12
医麦创新药2025-12-12
求实药社2025-12-12
卫材中国2025-12-12
药时空2025-12-12
Being科学2025-12-12
康华股份2025-12-12
康臣药业2025-12-12
汉康生技2025-12-12